Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis. [electronic resource]
Producer: 20170825Description: 1062-8 p. digitalISSN:- 1502-7708
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Biosimilar Pharmaceuticals -- administration & dosage
- C-Reactive Protein -- analysis
- Colitis, Ulcerative -- drug therapy
- Crohn Disease -- drug therapy
- Czech Republic
- Female
- Gastrointestinal Agents -- administration & dosage
- Humans
- Infliximab -- administration & dosage
- Male
- Middle Aged
- Prospective Studies
- Remission Induction
- Sex Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.